184 related articles for article (PubMed ID: 35249555)
1. Transhiatal esophagectomy as a treatment for locally advanced adenocarcinoma of the gastroesophageal junction: postoperative and oncologic results of a single-center cohort THE for locally advanced GEJC.
Meillat H; Niziers V; Zemmour C; Ewald J; Ratone JP; Dermeche S; Guiramand J
World J Surg Oncol; 2022 Mar; 20(1):70. PubMed ID: 35249555
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation.
Coker AM; Barajas-Gamboa JS; Cheverie J; Jacobsen GR; Sandler BJ; Talamini MA; Bouvet M; Horgan S
J Laparoendosc Adv Surg Tech A; 2014 Feb; 24(2):89-94. PubMed ID: 24401141
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of laparoscopic-assisted transhiatal esophagectomy for adenocarcinoma of the esophagus and esophago-gastric junction.
Montenovo MI; Chambers K; Pellegrini CA; Oelschlager BK
Dis Esophagus; 2011 Aug; 24(6):430-6. PubMed ID: 21309915
[TBL] [Abstract][Full Text] [Related]
4. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
6. Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis.
Plum PS; Damanakis A; Buschmann L; Ernst A; Datta RR; Schiffmann LM; Zander T; Fuchs H; Chon SH; Alakus H; Schröder W; Hölscher AH; Bruns CJ; Bludau M
J Cancer Res Clin Oncol; 2022 May; 148(5):1223-1234. PubMed ID: 34223965
[TBL] [Abstract][Full Text] [Related]
7. Robot-assisted transhiatal esophagectomy: a 3-year single-center experience.
Dunn DH; Johnson EM; Morphew JA; Dilworth HP; Krueger JL; Banerji N
Dis Esophagus; 2013; 26(2):159-66. PubMed ID: 22394116
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-volume Center Retrospective Cohort Analysis.
Wirsik NM; Schmidt T; Nienhüser H; Donlon NE; de Jongh C; Uzun E; Fuchs HF; Brunner S; Alakus H; Hölscher AH; Grimminger P; Schneider M; Reynolds JV; van Hillegersberg R; Bruns CJ
Ann Surg; 2023 Nov; 278(5):683-691. PubMed ID: 37522845
[TBL] [Abstract][Full Text] [Related]
9. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Radiochemotherapy for Patients with Locally Advanced Esophagogastric Junction Adenocarcinoma.
Marica CD; Birlă R; Marica R; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2018; 113(2):192-201. PubMed ID: 29733013
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection.
Cooke DT; Lin GC; Lau CL; Zhang L; Si MS; Lee J; Chang AC; Pickens A; Orringer MB
Ann Thorac Surg; 2009 Jul; 88(1):177-84; discussion 184-5. PubMed ID: 19559221
[TBL] [Abstract][Full Text] [Related]
12. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
[TBL] [Abstract][Full Text] [Related]
13. Operative and survival outcomes in a series of 100 consecutive cases of robot-assisted transhiatal esophagectomies.
Dunn DH; Johnson EM; Anderson CA; Krueger JL; DeFor TE; Morphew JA; Banerji N
Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859385
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
[TBL] [Abstract][Full Text] [Related]
15. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after transhiatal and transthoracic esophagectomy for cancer.
Chang AC; Ji H; Birkmeyer NJ; Orringer MB; Birkmeyer JD
Ann Thorac Surg; 2008 Feb; 85(2):424-9. PubMed ID: 18222237
[TBL] [Abstract][Full Text] [Related]
18. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.
Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL
Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563
[TBL] [Abstract][Full Text] [Related]
19. A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
Kjaer DW; Nassar M; Jensen LS; Svendsen LB; Mortensen FV
Dis Esophagus; 2017 Feb; 30(3):1-7. PubMed ID: 27001181
[TBL] [Abstract][Full Text] [Related]
20. Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study.
Kalff MC; van Berge Henegouwen MI; Baas PC; Bahadoer RR; Belt EJT; Brattinga B; Claassen L; Ćosović A; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; Drost M; van Duijvendijk P; Eshuis WJ; van Esser S; Gaspersz MP; Görgec B; Groenendijk RPR; Hartgrink HH; van der Harst E; Haveman JW; Heisterkamp J; van Hillegersberg R; Kelder W; Kingma BF; Koemans WJ; Kouwenhoven EA; Lagarde SM; Lecot F; van der Linden PP; Luyer MDP; Nieuwenhuijzen GAP; Olthof PB; van der Peet DL; Pierie JEN; Pierik EGJMR; Plat VD; Polat F; Rosman C; Ruurda JP; van Sandick JW; Scheer R; Slootmans CAM; Sosef MN; Sosef OV; de Steur WO; Stockmann HBAC; Stoop FJ; Voeten DM; Vugts G; Vijgen GHEJ; Weeda VB; Wiezer MJ; van Oijen MGH; Gisbertz SS
Ann Surg; 2023 Apr; 277(4):619-628. PubMed ID: 35129488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
